| Breakdown | TTM | Dec 2025 | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.29B | 73.30B | 57.44B | 44.08B | 31.75B | 23.35B |
| Gross Profit | 13.51B | 11.86B | 9.38B | 7.04B | 4.15B | 3.03B |
| EBITDA | 1.10B | 1.24B | 3.49B | 2.43B | 1.55B | 819.01M |
| Net Income | -3.28B | -2.66B | 334.42M | -306.15M | -550.67M | -825.94M |
Balance Sheet | ||||||
| Total Assets | 1.79B | 30.58B | 22.78B | 14.96B | 11.79B | 8.05B |
| Cash, Cash Equivalents and Short-Term Investments | 225.70M | 4.15B | 4.47B | 1.22B | 984.63M | 1.00B |
| Total Debt | 808.94M | 14.00B | 9.20B | 11.91B | 10.55B | 8.13B |
| Total Liabilities | 1.55B | 26.44B | 18.74B | 19.60B | 16.51B | 12.50B |
| Stockholders Equity | 237.71M | 4.13B | 4.03B | -4.63B | -4.71B | -4.45B |
Cash Flow | ||||||
| Free Cash Flow | 1.73B | 1.13B | 1.31B | 1.34B | 990.65M | 832.27M |
| Operating Cash Flow | 5.48B | 4.46B | 3.75B | 3.14B | 2.12B | 1.37B |
| Investing Cash Flow | -3.64B | -3.35B | -4.91B | -1.78B | -1.11B | -524.08M |
| Financing Cash Flow | -2.04B | -1.09B | 1.29B | -1.10B | -1.03B | -450.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $5.09B | 23.80 | 12.00% | 1.02% | 8.85% | 8.03% | |
72 Outperform | $11.34B | 29.29 | 12.71% | ― | 17.97% | 290.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $11.06B | 21.07 | 25.45% | ― | 5.92% | 0.80% | |
56 Neutral | $23.27B | 18.52 | 18.66% | 1.88% | 5.20% | 34.26% | |
56 Neutral | $18.50B | 11.56 | 34.83% | ― | -29.62% | ― | |
52 Neutral | $4.33B | -33.30 | -102.61% | ― | 41.20% | -733.48% |